News and Events Overview

Maroon background with University of Minnesota block M logo

The following students received American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowships for the 2022-2023 academic year. These prestigious competitive fellowships are awarded to "high performing students who possess the skill and aptitude to become outstanding scientists and leaders in the pharmaceutical industry, academia, and the government/nonprofit sectors.”

Patient being examined by an Optometrist

The results of Phase 2 clinical trials for glaucoma drug QLS-101 have demonstrated a favorable safety and tolerability profile, according to a news release by Qlaris Bio, which licensed the drug in 2019. A positive efficacy signal was also reported.

Dr. Daniel Harki Headshot

The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established in response to the public health emergency.

Scientist working with tubes

Thanks to a research collaboration between the Institute for Therapeutics Discovery & Development and Mayo Clinic, a drug that shows promise for glaucoma patients has moved to Phase I/II clinical trials.

Carston R. Wagner Headshot

Carston “Rick” Wagner, PhD, has been named the 2021 recipient of the American Association of Colleges of Pharmacy’s (AACP) Volwiler Research Achievement Award.

Adam Duerfeldt Headshot

Associate professor Adam Duerfeldt, PhD, joined the College of Pharmacy’s Department of Medicinal Chemistry on Dec. 28, 2020.